BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 11895487)

  • 1. Secretory carcinoma of the breast: a tumour analogous to salivary gland acinic cell carcinoma?
    Hirokawa M; Sugihara K; Sai T; Monobe Y; Kudo H; Sano N; Sano T
    Histopathology; 2002 Mar; 40(3):223-9. PubMed ID: 11895487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Searching for mammary analogue [corrected] secretory carcinoma of salivary gland among its mimics.
    Pinto A; Nosé V; Rojas C; Fan YS; Gomez-Fernandez C
    Mod Pathol; 2014 Jan; 27(1):30-7. PubMed ID: 23807775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Most nonparotid "acinic cell carcinomas" represent mammary analog secretory carcinomas.
    Bishop JA; Yonescu R; Batista D; Eisele DW; Westra WH
    Am J Surg Pathol; 2013 Jul; 37(7):1053-7. PubMed ID: 23681074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemistry with a pan-TRK antibody distinguishes secretory carcinoma of the salivary gland from acinic cell carcinoma.
    Hung YP; Jo VY; Hornick JL
    Histopathology; 2019 Jul; 75(1):54-62. PubMed ID: 30801752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers.
    Urano M; Nagao T; Miyabe S; Ishibashi K; Higuchi K; Kuroda M
    Hum Pathol; 2015 Jan; 46(1):94-103. PubMed ID: 25456394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary gland-type tumors of the breast: a spectrum of benign and malignant tumors including "triple negative carcinomas" of low malignant potential.
    Foschini MP; Krausz T
    Semin Diagn Pathol; 2010 Feb; 27(1):77-90. PubMed ID: 20306833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acinic cell-like carcinoma of the breast.
    Roncaroli F; Lamovec J; Zidar A; Eusebi V
    Virchows Arch; 1996 Sep; 429(1):69-74. PubMed ID: 8865856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acinic cell carcinoma of the breast: an immunohistochemical and ultrastructural study.
    Damiani S; Pasquinelli G; Lamovec J; Peterse JL; Eusebi V
    Virchows Arch; 2000 Jul; 437(1):74-81. PubMed ID: 10963383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity.
    Connor A; Perez-Ordoñez B; Shago M; Skálová A; Weinreb I
    Am J Surg Pathol; 2012 Jan; 36(1):27-34. PubMed ID: 21989350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zymogen-poor acinic cell carcinoma of the soft palate with high-grade transformation.
    Kallarakkal TG; Ismail SM; Goh YC
    Malays J Pathol; 2022 Apr; 44(1):121-127. PubMed ID: 35484895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acinic cell carcinoma of the breast: A comprehensive review.
    Ajkunic A; Skenderi F; Shaker N; Akhtar S; Lamovec J; Gatalica Z; Vranic S
    Breast; 2022 Dec; 66():208-216. PubMed ID: 36332545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysozyme Expression Can be Useful to Distinguish Mammary Analog Secretory Carcinoma from Acinic Cell Carcinoma of Salivary Glands.
    Mariano FV; Gómez CA; de Souza do Nascimento J; Dos Santos HT; Egal ES; Montalli VA; Vargas PA; de Almeida OP; Altemani A
    Head Neck Pathol; 2016 Dec; 10(4):429-436. PubMed ID: 27177644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papillary-cystic pattern is characteristic in mammary analogue secretory carcinomas but is rarely observed in acinic cell carcinomas of the salivary gland.
    Hsieh MS; Chou YH; Yeh SJ; Chang YL
    Virchows Arch; 2015 Aug; 467(2):145-53. PubMed ID: 25976476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammaglobin and S-100 immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma.
    Patel KR; Solomon IH; El-Mofty SK; Lewis JS; Chernock RD
    Hum Pathol; 2013 Nov; 44(11):2501-8. PubMed ID: 24029710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocytochemistry of acinic cell carcinomas and mixed tumors of salivary glands.
    Warner TF; Seo IS; Azen EA; Hafez GR; Zarling TA
    Cancer; 1985 Nov; 56(9):2221-7. PubMed ID: 2413984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MASC is indistinguishable from acinic cell carcinoma, papillary-cystic variant on salivary gland FNA cytomorphology: case report with histological and immunohistochemical correlates.
    Bellevicine C; Natella V; Somma A; De Rosa G; Troncone G
    Cytopathology; 2014 Oct; 25(5):344-6. PubMed ID: 24138633
    [No Abstract]   [Full Text] [Related]  

  • 17. Carbonic anhydrase VI: a novel marker for salivary serous acinar differentiation and its application to discriminate acinic cell carcinoma from mammary analogue secretory carcinoma of the salivary gland.
    Hsieh MS; Jeng YM; Jhuang YL; Chou YH; Lin CY
    Histopathology; 2016 Apr; 68(5):641-7. PubMed ID: 26212680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acinic cell carcinoma of the breast: review of the literature.
    Limite G; Di Micco R; Esposito E; Sollazzo V; Cervotti M; Pettinato G; Varone V; Benassai G; Amato B; Pilone V; Luglio G; Vitiello A; Hasani A; Liccardo F; Forestieri P
    Int J Surg; 2014; 12 Suppl 1():S35-9. PubMed ID: 24859406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The many faces of acinic cell carcinomas of the salivary glands: a study of 40 cases relating histological and immunohistological subtypes to clinical parameters and prognosis.
    Schwarz S; Zenk J; Müller M; Ettl T; Wünsch PH; Hartmann A; Agaimy A
    Histopathology; 2012 Sep; 61(3):395-408. PubMed ID: 22551398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mist1: a novel nuclear marker for acinic cell carcinoma of the salivary gland.
    Hsieh MS; Jeng YM; Lee YH
    Virchows Arch; 2019 Nov; 475(5):617-624. PubMed ID: 31187185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.